CAS: 1345982-69-5
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Linerixibat REF: TM-T3978CAS: 1345982-69-5 | 98.5% - 99.83% | 82,00 €~832,00 € | Vie 17 Ene 25 |
 | Linerixibat REF: 4Z-L-217001CAS: 1345982-69-5 | - - - | A consultar | Vie 17 Ene 25 |
 | Linerixibat REF: 3D-VDC98269CAS: 1345982-69-5 | Min. 95% | A consultar | Vie 21 Feb 25 |
 | GSK 2330672 REF: IN-DA009CBXCAS: 1345982-69-5 | 98% | - - - | Producto descatalogado |
Linerixibat
CAS:1345982-69-5
Linerixibat (GSK2330672) is a highly effective, nonabsorbable ASBT inhibitor. Linerixibat can lower glucose in an …
Fórmula:
C28H38N2O7S
Pureza:
98.5% - 99.83%
Forma y color:
Solid
Peso molecular:
546.68
Ref: TM-T3978
| 1mg | 82,00 € | ||
| 2mg | 115,00 € | ||
| 5mg | 207,00 € | ||
| 10mg | 348,00 € | ||
| 25mg | 588,00 € | ||
| 50mg | 832,00 € | ||
| 1mL*10mM (DMSO) | 252,00 € |
Entrega estimada en Estados Unidos, el Viernes 17 de Enero de 2025
Ref: 4Z-L-217001
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Viernes 17 de Enero de 2025
Linerixibat
CAS:1345982-69-5
Linerixibat is a drug that has been shown to reduce the accumulation of fat in …
Fórmula:
C28H38N2O7S
Pureza:
Min. 95%
Peso molecular:
546.68 g/mol
Ref: 3D-VDC98269
| 10mg | 1.026,00 € | ||
| 25mg | 1.573,00 € | ||
| 50mg | 2.517,00 € |
Entrega estimada en Estados Unidos, el Viernes 21 de Febrero de 2025
Ref: IN-DA009CBX
| 1mg | Descatalogado | Solicitar información | |
| 2mg | Descatalogado | Solicitar información | |
| 5mg | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información |
